Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedAssets was a prominent healthcare performance improvement company that provided technology-enabled solutions and services to hospitals and health systems across the United States. The company focused on two core areas: Spend Management, which included Group Purchasing Organization (GPO) services and supply chain consulting, and Revenue Cycle Management (RCM) software and services. By leveraging data analytics and SaaS-based platforms, MedAssets helped healthcare providers reduce operating costs, optimize clinical resource utilization, and improve financial performance. In 2016, the company was acquired by Pamplona Capital Management for approximately $2.7 billion, after which its GPO business was sold to Vizient and its RCM business was merged with Precyse to form nThrive (now FinThrive).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedAssets.